Skip to main content

Table 1 KEGG pathways enriched in murine macrophages at 4 hpi. KEGG pathway analysis using ConsensusPathDB [58] identified signaling and metabolic pathways that were over-represented in L. major-infected mouse macrophages at 4 hpi (P value < 0.01) relative to uninfected controls. Genes that were differentially expressed (DE) by more than 2-fold were used as input with up- and downregulated genes considered separately. For each enriched KEGG pathway, the number of DE genes assigned to that pathway, the total number of genes in the pathway, and the P value for the enrichment are reported. The differentially expressed genes corresponding to each enriched KEGG pathway are reported in Additional file 4

From: Simultaneous transcriptional profiling of Leishmania major and its murine macrophage host cell reveals insights into host-pathogen interactions

KEGG pathway, upregulated

Number DE Genes

Pathway Size

P Value

  Cytokine-cytokine receptor interaction

43

266

3.49e-12

  TNF signaling pathway

24

111

3.05e-09

  Transcriptional misregulation in cancer

24

180

5.72e-09

  HIF-1 signaling pathway

20

113

4.57e-07

  Hematopoietic cell lineage

16

87

5.84e-07

  NF-kappa B signaling pathway

19

102

1.55e-06

  Jak-STAT signaling pathway

22

155

2.24e-06

  Legionellosis

13

59

1.05e-05

  PI3K-Akt signaling pathway

37

353

6.29e-05

  MAPK signaling pathway

28

257

2.57e-04

  Salmonella infection

12

79

9.24e-04

  Malaria

9

49

1.00e-03

  NOD-like receptor signaling pathway

10

59

1.03e-03

  Rheumatoid arthritis

12

84

1.60e-03

  Glycolysis/Gluconeogenesis

9

65

2.19e-03

  Mineral absorption

8

46

2.72e-03

  ECM-receptor interaction

11

87

6.42e-03

  Tuberculosis

18

177

6.45e-03

  Gap junction

11

88

7.00e-03

  Axon guidance

14

129

8.88e-03

  Arginine and proline metabolism

8

56

9.30e-03

  Prion diseases

6

35

9.77e-03

KEGG pathway, downregulated

Number DE Genes

Pathway Size

P Value

  Osteoclast differentiation

21

126

2.99e-06

  Terpenoid backbone biosynthesis

7

21

7.30e-05

  Staphylococcus aureus infection

11

52

7.61e-05

  Steroid biosynthesis

6

17

1.71e-04

  NOD-like receptor signaling pathway

10

59

2.51e-04

  Peroxisome

12

81

1.18e-03

  PPAR signaling pathway

12

81

1.18e-03

  Chagas disease (American trypanosomiasis)

14

104

1.24e-03

  Biosynthesis of unsaturated fatty acids

6

25

1.69e-03

  Leishmaniasis

10

66

2.50e-03

  ABC transporters

8

46

2.75e-03

  Axon guidance

15

129

3.69e-03

  Leukocyte transendothelial migration

14

121

5.16e-03

  Fc gamma R-mediated phagocytosis

11

89

7.70e-03

  Pancreatic cancer

9

67

9.02e-03